CHRISTOPHER EARLES: Open Payments
NPI 1750431854 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,445 in 28 payments from 15 companies in 2025. Trend: 2023 $174 · 2024 $1,903 · 2025 $2,445
Food & beverage: $2,368Education: $77
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 2 | $347 |
| Janssen Biotech, Inc. | 4 | $341 |
| Phathom Pharmaceuticals, Inc. | 3 | $307 |
| AstraZeneca Pharmaceuticals LP | 3 | $285 |
| GENZYME CORPORATION | 2 | $279 |
| ABBVIE INC. | 3 | $205 |
| PFIZER INC. | 2 | $140 |
| Madrigal Pharmaceuticals | 1 | $121 |
| Ipsen Biopharmaceuticals, Inc | 1 | $96 |
| Lilly USA, LLC | 1 | $95 |
Products named: TREMFYA, VOQUEZNA, AIRSUPRA, DUPIXENT, VELSIPITY, REZDIFFRA, SKYRIZI, IQIRVO.
Industry payments across TX — which companies pay providers there.
